| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
|
N Engl J Med
|
2001
|
10.56
|
|
2
|
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
|
Pediatrics
|
1977
|
4.64
|
|
3
|
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.
|
J Infect Dis
|
1983
|
4.05
|
|
4
|
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.
|
N Engl J Med
|
1984
|
3.37
|
|
5
|
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
|
N Engl J Med
|
1977
|
3.32
|
|
6
|
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
|
N Engl J Med
|
1990
|
2.90
|
|
7
|
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
|
J Infect Dis
|
1991
|
2.83
|
|
8
|
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
|
J Infect Dis
|
1977
|
2.79
|
|
9
|
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.
|
J Clin Microbiol
|
1994
|
2.63
|
|
10
|
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
|
N Engl J Med
|
1987
|
2.47
|
|
11
|
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
|
J Infect Dis
|
2000
|
2.11
|
|
12
|
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.
|
J Clin Microbiol
|
2000
|
1.97
|
|
13
|
Effect of group-A meningococcal vaccine in army recruits in Finland.
|
Lancet
|
1975
|
1.97
|
|
14
|
Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
|
J Infect Dis
|
1998
|
1.76
|
|
15
|
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.
|
Clin Diagn Lab Immunol
|
1996
|
1.71
|
|
16
|
Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.
|
J Infect Dis
|
1981
|
1.65
|
|
17
|
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
|
Pediatrics
|
1984
|
1.65
|
|
18
|
Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
|
Lancet
|
1997
|
1.62
|
|
19
|
Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae.
|
Clin Exp Immunol
|
1999
|
1.56
|
|
20
|
Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
|
J Infect Dis
|
2001
|
1.55
|
|
21
|
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
|
J Infect Dis
|
1980
|
1.53
|
|
22
|
Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?
|
Clin Diagn Lab Immunol
|
2000
|
1.52
|
|
23
|
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.
|
Lancet
|
1985
|
1.52
|
|
24
|
Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children.
|
J Infect Dis
|
2001
|
1.51
|
|
25
|
Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis.
|
J Infect Dis
|
1982
|
1.45
|
|
26
|
Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.
|
Vaccine
|
1999
|
1.43
|
|
27
|
Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
|
J Immunol
|
1987
|
1.38
|
|
28
|
Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
|
Acta Paediatr
|
1999
|
1.38
|
|
29
|
Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.
|
Pediatr Infect Dis J
|
1998
|
1.37
|
|
30
|
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides.
|
Pediatrics
|
1985
|
1.34
|
|
31
|
Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals.
|
J Infect Dis
|
1993
|
1.27
|
|
32
|
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
|
J Infect Dis
|
2001
|
1.25
|
|
33
|
IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
|
Vaccine
|
1999
|
1.24
|
|
34
|
Current state of pneumococcal vaccines.
|
Scand J Immunol
|
2002
|
1.19
|
|
35
|
Comparison of counter-current immunoelectrophoresis, latex agglutination, and radioimmunoassay in detection of soluble capsular polysaccharide antigens of Haemophilus influenzae type b and Neisseria meningitidis of groups A or C.
|
J Clin Pathol
|
1978
|
1.19
|
|
36
|
Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.
|
J Infect Dis
|
1993
|
1.16
|
|
37
|
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
|
J Infect Dis
|
2001
|
1.16
|
|
38
|
Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.
|
Pediatr Infect Dis J
|
1995
|
1.15
|
|
39
|
Isotype concentrations of human antibodies to group A meningococcal polysaccharide.
|
J Immunol
|
1986
|
1.12
|
|
40
|
Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin.
|
Scand J Immunol
|
1988
|
1.11
|
|
41
|
Genes involved in Haemophilus influenzae type b capsule expression are frequently amplified.
|
J Infect Dis
|
1993
|
1.10
|
|
42
|
Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum.
|
Vaccine
|
1998
|
1.10
|
|
43
|
Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
|
Pediatr Infect Dis J
|
1996
|
1.10
|
|
44
|
Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
|
Pediatr Infect Dis J
|
2001
|
1.09
|
|
45
|
Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children.
|
Pediatr Infect Dis J
|
1993
|
1.08
|
|
46
|
Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.
|
Clin Diagn Lab Immunol
|
1998
|
1.07
|
|
47
|
Radioimmunoassay of capsular polysaccharide antigens of groups A and C meningococci and Haemophilus influenzae type b in cerebrospinal fluid.
|
J Clin Pathol
|
1977
|
1.07
|
|
48
|
Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.
|
Eur J Clin Microbiol Infect Dis
|
1989
|
1.06
|
|
49
|
Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid.
|
J Infect Dis
|
1987
|
1.06
|
|
50
|
Distinct geographic distribution of subtypes of Haemophilus influenzae type b in Western Europe.
|
J Infect Dis
|
1987
|
1.06
|
|
51
|
Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?
|
Clin Diagn Lab Immunol
|
2001
|
1.05
|
|
52
|
Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide.
|
J Pediatr
|
1978
|
1.04
|
|
53
|
Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media.
|
Pediatr Infect Dis J
|
2001
|
1.04
|
|
54
|
The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci.
|
Vaccine
|
1999
|
1.04
|
|
55
|
Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys.
|
Infect Immun
|
1992
|
1.00
|
|
56
|
Monoclonal antibodies to the rough lipopolysaccharide of Neisseria meningitidis protect infant rats from meningococcal infection.
|
J Infect Dis
|
1988
|
0.98
|
|
57
|
Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine.
|
Clin Exp Immunol
|
1995
|
0.97
|
|
58
|
Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
|
Pediatrics
|
1995
|
0.97
|
|
59
|
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
|
Vaccine
|
2000
|
0.96
|
|
60
|
Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults.
|
Vaccine
|
2001
|
0.95
|
|
61
|
Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy.
|
Arch Pediatr Adolesc Med
|
1994
|
0.95
|
|
62
|
Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine.
|
J Clin Microbiol
|
1980
|
0.95
|
|
63
|
Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis.
|
Infect Immun
|
1993
|
0.94
|
|
64
|
Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.
|
Vaccine
|
2000
|
0.94
|
|
65
|
Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response.
|
Vaccine
|
1998
|
0.94
|
|
66
|
Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia.
|
Br J Haematol
|
2001
|
0.94
|
|
67
|
Monoclonal antibodies specific to porin of Haemophilus influenzae type b: localization of their cognate epitopes and tests of their biological activities.
|
Mol Microbiol
|
1992
|
0.94
|
|
68
|
Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy.
|
Vaccine
|
1996
|
0.93
|
|
69
|
Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.
|
Clin Diagn Lab Immunol
|
2001
|
0.93
|
|
70
|
Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
|
Pediatr Infect Dis J
|
1999
|
0.93
|
|
71
|
Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.
|
Vaccine
|
1999
|
0.92
|
|
72
|
Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
|
Microb Pathog
|
2001
|
0.92
|
|
73
|
Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.
|
Can J Microbiol
|
1986
|
0.91
|
|
74
|
Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine.
|
Scand J Immunol
|
2001
|
0.90
|
|
75
|
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers.
|
Pediatr Infect Dis J
|
2001
|
0.90
|
|
76
|
Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.
|
Vaccine
|
2001
|
0.90
|
|
77
|
Dynamics of natural immunity caused by subclinical infections, case study on Haemophilus influenzae type b (Hib).
|
Epidemiol Infect
|
2000
|
0.89
|
|
78
|
Clinical evaluation of new pneumococcal vaccines: the Finnish approach.
|
Dev Biol Stand
|
1998
|
0.89
|
|
79
|
Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines.
|
Vaccine
|
2003
|
0.89
|
|
80
|
Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.
|
Clin Exp Immunol
|
2013
|
0.87
|
|
81
|
Human antibodies to pneumococcal surface protein A in health and disease.
|
Pediatr Infect Dis J
|
2000
|
0.87
|
|
82
|
Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.
|
Infect Immun
|
1996
|
0.87
|
|
83
|
Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood.
|
Pediatr Infect Dis J
|
1988
|
0.87
|
|
84
|
Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
|
J Pediatr
|
1996
|
0.87
|
|
85
|
Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model.
|
J Infect Dis
|
1996
|
0.86
|
|
86
|
A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
|
Bone Marrow Transplant
|
1996
|
0.85
|
|
87
|
Clinical experience with Haemophilus influenzae type b conjugate vaccines.
|
Pediatrics
|
1990
|
0.85
|
|
88
|
Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine.
|
J Infect Dis
|
1983
|
0.85
|
|
89
|
Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.
|
Vaccine
|
2001
|
0.85
|
|
90
|
Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine.
|
Bone Marrow Transplant
|
2001
|
0.85
|
|
91
|
Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation.
|
APMIS
|
1996
|
0.85
|
|
92
|
Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?
|
J Infect Dis
|
2001
|
0.84
|
|
93
|
Effect of Gm allotypes on IgG2 antibody responses and IgG2 concentrations in children and adults.
|
Int Immunol
|
1990
|
0.83
|
|
94
|
A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
2007
|
0.83
|
|
95
|
IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
|
Bone Marrow Transplant
|
1999
|
0.83
|
|
96
|
Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients.
|
Bone Marrow Transplant
|
2001
|
0.83
|
|
97
|
Haemophilus influenzae type b and cross-reactive antigens in natural Hib infection dynamics; modelling in two populations.
|
Epidemiol Infect
|
2002
|
0.82
|
|
98
|
Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.
|
J Infect Dis
|
1995
|
0.82
|
|
99
|
The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases.
|
Parasite Immunol
|
1982
|
0.82
|
|
100
|
Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100.
|
Vaccine
|
1996
|
0.82
|
|
101
|
Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b.
|
J Infect
|
1987
|
0.82
|
|
102
|
Interactions of Haemophilus influenzae with human endothelial cells in vitro.
|
J Infect Dis
|
1992
|
0.82
|
|
103
|
Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.
|
Clin Exp Immunol
|
2006
|
0.81
|
|
104
|
Antibodies to pneumolysin and pneumococcal capsular polysaccharides in middle ear fluid of children with acute otitis media.
|
Acta Otolaryngol
|
1995
|
0.81
|
|
105
|
Determination of antibody responses to meningococcal antigens by ELISA.
|
Methods Mol Med
|
2001
|
0.81
|
|
106
|
Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.
|
Clin Diagn Lab Immunol
|
1995
|
0.81
|
|
107
|
Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy.
|
Pediatr Infect Dis J
|
1996
|
0.81
|
|
108
|
Experience in Finland with Haemophilus influenzae type b vaccines.
|
Vaccine
|
1991
|
0.80
|
|
109
|
Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
|
Pediatr Infect Dis J
|
1999
|
0.80
|
|
110
|
Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.
|
Clin Exp Immunol
|
1998
|
0.80
|
|
111
|
Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in saliva.
|
Clin Diagn Lab Immunol
|
2003
|
0.79
|
|
112
|
B and T cell immunity in patients with lysinuric protein intolerance.
|
Clin Exp Immunol
|
1999
|
0.79
|
|
113
|
A hierarchical Bayesian model to predict the duration of immunity to Haemophilus influenzae type b.
|
Biometrics
|
1999
|
0.79
|
|
114
|
Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media.
|
J Infect Dis
|
1995
|
0.79
|
|
115
|
[Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
|
Duodecim
|
1983
|
0.78
|
|
116
|
Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media.
|
J Infect Dis
|
1996
|
0.78
|
|
117
|
Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
|
J Clin Immunol
|
2000
|
0.78
|
|
118
|
New vaccines for prevention of pneumococcal infections.
|
Ann Med
|
1995
|
0.78
|
|
119
|
Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
|
Curr Opin Pediatr
|
1993
|
0.77
|
|
120
|
Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.
|
Vaccine
|
2001
|
0.77
|
|
121
|
Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomy.
|
Eur J Clin Microbiol Infect Dis
|
2011
|
0.77
|
|
122
|
Concentrations of serum immunoglobulins and antibodies to pneumococcal capsular polysaccharides in patients with recurrent or chronic sinusitis.
|
Ann Otol Rhinol Laryngol
|
2001
|
0.77
|
|
123
|
Latex agglutination test for screening of Haemophilus influenzae type b carriers.
|
J Clin Microbiol
|
1987
|
0.77
|
|
124
|
Finnish efficacy trials with Haemophilus influenzae type b vaccines.
|
J Infect Dis
|
1992
|
0.76
|
|
125
|
Early immunization with conjugate vaccines.
|
Vaccine
|
1998
|
0.76
|
|
126
|
Vaccination of children during treatment for leukemia.
|
Acta Paediatr Scand
|
1986
|
0.75
|
|
127
|
Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination.
|
Scand J Infect Dis
|
1996
|
0.75
|
|
128
|
[Severe Haemophilus influenzae infections in children are contagious].
|
Duodecim
|
1986
|
0.75
|
|
129
|
Vaccines for Haemophilus influenzae type b as models for an otitis vaccine.
|
Pediatr Infect Dis J
|
1989
|
0.75
|
|
130
|
Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
|
Vaccine
|
1990
|
0.75
|
|
131
|
[New specific bacterial vaccines].
|
Duodecim
|
1976
|
0.75
|
|
132
|
Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
|
Pediatr Infect Dis J
|
1994
|
0.75
|
|
133
|
Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.
|
Vaccine
|
1998
|
0.75
|
|
134
|
[Why is the genome sequencing of meningococcus useful for us?].
|
Duodecim
|
2000
|
0.75
|
|
135
|
[Vaccine against Haemophilus influenzae type b--antibody response and adverse effects].
|
Tidsskr Nor Laegeforen
|
1995
|
0.75
|
|
136
|
[The bactericidal action of human neutrophils on meningococci in vitro].
|
Zh Mikrobiol Epidemiol Immunobiol
|
2000
|
0.75
|
|
137
|
Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.
|
Vaccine
|
1999
|
0.75
|
|
138
|
Detection of antibody responses against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis proteins in children with community-acquired pneumonia: effects of combining pneumococcal antigens, pre-existing antibody levels, sampling interval, age, and duration of illness.
|
Eur J Clin Microbiol Infect Dis
|
2015
|
0.75
|
|
139
|
Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
|
J Infect
|
1983
|
0.75
|